日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

达雷妥尤单抗联合来那度胺作为新诊断多发性骨髓瘤移植后维持治疗:AURIGA 研究

Badros, Ashraf; Foster, Laahn; Anderson, Larry D Jr; Chaulagain, Chakra P; Pettijohn, Erin; Cowan, Andrew J; Costello, Caitlin; Larson, Sarah; Sborov, Douglas W; Shain, Kenneth H; Silbermann, Rebecca; Shah, Nina; Chung, Alfred; Krevvata, Maria; Pei, Huiling; Patel, Sharmila; Khare, Vipin; Cortoos, Annelore; Carson, Robin; Lin, Thomas S; Voorhees, Peter

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses

移植后新诊断的多发性骨髓瘤患者接受达雷妥尤单抗联合来那度胺维持治疗:AURIGA 亚组分析

Foster, Laahn; Anderson, Larry D Jr; Chung, Alfred; Chaulagain, Chakra P; Pettijohn, Erin; Cowan, Andrew J; Costello, Caitlin; Larson, Sarah; Sborov, Douglas W; Shain, Kenneth H; Silbermann, Rebecca; Voorhees, Peter; Krevvata, Maria; Pei, Huiling; Patel, Sharmila; Khare, Vipin; Cortoos, Annelore; Carson, Robin; Lin, Thomas S; Badros, Ashraf

A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma

GRIFFIN 研究最终分析的简明语言摘要,该研究评估了达雷妥尤单抗联合来那度胺、硼替佐米和地塞米松治疗新诊断多发性骨髓瘤患者的疗效。

Voorhees, Peter M; Sborov, Douglas W; Laubach, Jacob; Kaufman, Jonathan L; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Efebera, Yvonne A; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Dinner, Shira; Gries, Katharine S; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Usmani, Saad Z; Richardson, Paul G

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

达雷妥尤单抗四联疗法用于适合移植且新诊断为多发性骨髓瘤、具有高细胞遗传学风险的患者

Callander, Natalie S; Silbermann, Rebecca; Kaufman, Jonathan L; Godby, Kelly N; Laubach, Jacob; Schmidt, Timothy M; Sborov, Douglas W; Medvedova, Eva; Reeves, Brandi; Dhakal, Binod; Rodriguez, Cesar; Chhabra, Saurabh; Chari, Ajai; Bal, Susan; Anderson, Larry D Jr; Dholaria, Bhagirathbhai R; Nathwani, Nitya; Hari, Parameswaran; Shah, Nina; Bumma, Naresh; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Giri, Smith; Costa, Luciano J; Usmani, Saad Z; Richardson, Paul G; Voorhees, Peter M

Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN

在适合移植的新诊断多发性骨髓瘤患者中应用达雷妥尤单抗:GRIFFIN研究中具有临床意义的亚组的最终分析

Chari, Ajai; Kaufman, Jonathan L; Laubach, Jacob; Sborov, Douglas W; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Voorhees, Peter M; Usmani, Saad Z; Richardson, Paul G

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers

梅奥诊所输液中心多发性骨髓瘤患者皮下和静脉注射达雷妥尤单抗的临床给药特征

Soefje, Scott A; Carpenter, Corinne; Carlson, Katherine; Awasthi, Samir; Lin, Thomas S; Kaila, Shuchita; Tarjan, Daniel; Kayal, Nikhil; Kirkup, Christian; Wagner, Tyler E; Gray, Kathleen S; Kumar, Shaji

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

在GRIFFIN研究中,达雷妥尤单抗联合来那度胺/硼替佐米/地塞米松治疗适合移植的黑人新诊断多发性骨髓瘤患者。

Nooka, Ajay K; Kaufman, Jonathan L; Rodriguez, Cesar; Jakubowiak, Andrzej; Efebera, Yvonne; Reeves, Brandi; Wildes, Tanya; Holstein, Sarah A; Anderson, Larry D Jr; Badros, Ashraf; Shune, Leyla; Chari, Ajai; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Bartlett, J Blake; Vermeulen, Jessica; Lin, Thomas S; Richardson, Paul G; Voorhees, Peter

Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma

达雷妥尤单抗可改善不适合移植的高危新诊断多发性骨髓瘤患者的缓解深度和无进展生存期

Jakubowiak, Andrzej J; Kumar, Shaji; Medhekar, Rohan; Pei, Huiling; Lefebvre, Patrick; Kaila, Shuchita; He, Jianming; Lafeuille, Marie-Hélène; Cortoos, Annelore; Londhe, Anil; Mavros, Panagiotis; Lin, Thomas S; Usmani, Saad Z

Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study

达雷妥尤单抗联合来那度胺、硼替佐米和地塞米松治疗新诊断的多发性骨髓瘤:GRIFFIN 研究中血管血栓事件的分析

Sborov, Douglas W; Baljevic, Muhamed; Reeves, Brandi; Laubach, Jacob; Efebera, Yvonne A; Rodriguez, Cesar; Costa, Luciano J; Chari, Ajai; Silbermann, Rebecca; Holstein, Sarah A; Anderson, Larry D Jr; Kaufman, Jonathan L; Shah, Nina; Pei, Huiling; Patel, Sharmila; Cortoos, Annelore; Bartlett, J Blake; Vermeulen, Jessica; Lin, Thomas S; Voorhees, Peter M; Richardson, Paul G

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial

达雷妥尤单抗、来那度胺、硼替佐米和地塞米松联合治疗适合移植的新诊断多发性骨髓瘤:GRIFFIN试验

Voorhees, Peter M; Kaufman, Jonathan L; Laubach, Jacob; Sborov, Douglas W; Reeves, Brandi; Rodriguez, Cesar; Chari, Ajai; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Efebera, Yvonne A; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Murphy, Sean; Lutska, Yana; Pei, Huiling; Ukropec, Jon; Vermeulen, Jessica; de Boer, Carla; Hoehn, Daniela; Lin, Thomas S; Richardson, Paul G